Cargando…
PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma
Effective strategies for hepatocellular carcinoma, which is the second leading cause of death worldwide, remain limited. A growing body of emerging evidence suggests that ferroptosis activation is a novel promising approach for the treatment of this malignancy. Nevertheless, the potential therapeuti...
Autores principales: | Hu, Xiaomeng, He, Yuchao, Han, Zhiqiang, Liu, Wei, Liu, Dongming, Zhang, Xihao, Chen, Lu, Qi, Lisha, Chen, Liwei, Luo, Yi, Li, Qiang, Chen, Peng, Wu, Qiang, Zhu, Xiaolin, Guo, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709074/ https://www.ncbi.nlm.nih.gov/pubmed/36446769 http://dx.doi.org/10.1038/s41419-022-05448-7 |
Ejemplares similares
-
PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway
por: Han, Zhiqiang, et al.
Publicado: (2021) -
PNO1, which is negatively regulated by miR-340-5p, promotes lung adenocarcinoma progression through Notch signaling pathway
por: Liu, Dongming, et al.
Publicado: (2020) -
Celecoxib Inhibits Hepatocellular Carcinoma Cell Growth and Migration by Targeting PNO1
por: Dai, Huijun, et al.
Publicado: (2019) -
Cytosolic phospholipase A2α modulates cell-matrix adhesion via the FAK/paxillin pathway in hepatocellular carcinoma
por: Guo, Piao, et al.
Publicado: (2019) -
DNAJC24 is a potential therapeutic target in hepatocellular carcinoma through affecting ammonia metabolism
por: Li, Guangtao, et al.
Publicado: (2022)